Amid a contentious debate, the Senate Finance Committee voted 19-9 to advance legislation introduced by Senators Chuck Grassley, R-Iowa, and Ron Wyden, D-Oregon, to rein in drug costs in Medicare and Medicaid; a House of Representatives subcommittee accused Juul Labs, maker of the ubiqutious e-cigarette device blamed for a youth vaping epidemic, of targeting children through health promotion activities at about a half dozen schools and summer camps; at their annual meeting this week, governors from around the country are discussing what they will do if a federal appeals court invalidates the Affordable Care Act.
Amid a contentious debate, the Senate Finance Committee voted 19-9 to advance legislation introduced by Senators Chuck Grassley, R-Iowa, and Ron Wyden, D-Oregon, to rein in drug costs in Medicare and Medicaid. But a number of Republican senators object to a measure that would cap drug prices paid by Medicare based on the rate of inflation, siding with manufacturers against their own leadership, Kaiser Health News reported. Meanwhile, Democrats, who support the bill, said they won’t allow a vote without the Republicans agreeing to hold votes on cementing insurance protections for people with preexisting conditions and also give federal health officials to negotiate drug prices.A House of Representatives subcommittee accused Juul Labs, maker of the ubiqutious e-cigarette device blamed for a youth vaping epidemic, of targeting children through health promotion activities at about a half dozen schools and summer camps, The Washington Post reported. The panel’s investigation, based on 55,000 documents, also showed the company had concerns about the program, which was short lived.At their annual meeting this week, governors from around the country are discussing what they will do if a federal appeals court invalidates the Affordable Care Act, The Associated Press reported. The National Governors Association is meeting in Utah, and some states led by Democrats, such as Nevada and New Mexico, are writing their own legislation and making contingency plans; Arkansas is looking to Congress to pass a new plan.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen